They bought back 50 or 60 thousand shares at an average price around $15 meaning 1.45 Million shares to be bought back still. The share price is so much lower now they should buy every share possible and remove 1.5 Million shares from circulation leaving just 48.5 Million CUV shares on issue which is an incredibly low number for a Biotech at this stage.
All IMO DYOR
- Forums
- ASX - By Stock
- CUV
- Ann: Notification of buy-back - CUV
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
0.51%
!
$9.71

Ann: Notification of buy-back - CUV, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$9.71 |
Change
-0.050(0.51%) |
Mkt cap ! $486.1M |
Open | High | Low | Value | Volume |
$9.58 | $9.90 | $9.44 | $923.5K | 95.19K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 46 | $9.71 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.72 | 142 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 252 | 9.680 |
5 | 256 | 9.670 |
1 | 55 | 9.660 |
3 | 1303 | 9.650 |
2 | 106 | 9.640 |
Price($) | Vol. | No. |
---|---|---|
9.710 | 268 | 5 |
9.720 | 74 | 2 |
9.730 | 191 | 6 |
9.740 | 396 | 5 |
9.750 | 87 | 3 |
Last trade - 14.53pm 18/06/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online